Congressional Budget Office Predicts Coronavirus Will Cost US Economy $15.7 Trillion

According to a recent forecast released by the Congressional Budget Office (CBO), the US is on track to lose approximately $7.9 trillion worth of economic activity over the next ten years, regardless of the federal government’s astronomical stimulus spending in order to prop up the economy.

Although many restrictions across the US are being lifted and both consumers and businesses are slowly starting to recover, the financial effects of the coronavirus pandemic are most likely going to be felt well into fiscal 2030. The report estimates that real economic output will be reduced by at least 3% when compared to previous pre-pandemic estimates, meanwhile nominal GDP will see a reduction of 5.3% – which translates to approximately $15.7 trillion.

Furthermore, the CBO is anticipating GDP levels to drop by the most in US history in the second quarter of 2020, while the month of May will have an unemployment rate of approximately 20% – the highest since the Great Depression. As a result, Senator Chuck Schumer is calling on the Senate to approve another round of fiscal stimulus in order to mitigate the impending negative impacts on the economy.

Information for this briefing was found via CNBC and the Congressional Budget Office. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Crossroads Gold Begins 2026 Exploration at Pambula, Reports Gold In Soil Up to 24.6 g/t

Questcorp Kicks Off Fully Funded Phase 2 Drilling at La Union

Related News

Revive Files Clinical Trial Application With Health Canada, Releases Phase 3 FDA Study Design For Potential Treatment Of COVID-19

Revive Therapeutics (CSE: RVV) continues to advance its clinical trial efforts. The company announced this...

Wednesday, June 3, 2020, 11:30:38 AM

Datametrex Acquires Rights To Sell COVID-19 Home Test Kit

Datametrex AI (TSXV: DM) this morning had significant news in that it has secured the...

Tuesday, June 16, 2020, 08:15:19 AM

Meat Processing Plants Turning to Robot Butchers to Reduce Coronavirus Infection Rates Among Workers

As the coronavirus pandemic continues to sweep across the US with record breaking infection rates,...

Sunday, July 12, 2020, 03:01:00 PM

Mortgage Borrowers No Longer Making Payments Due to Economic Shutdown: A Replay of the 2008 Subprime Mortgage Crisis?

The onset of the coronavirus pandemic has initiated an economic state much too familiar of...

Thursday, April 9, 2020, 08:42:22 AM

Increase in Rail Shipments Suggests Canadian Economy Beginning to Rebound

Much of Canada’s economy came to a stand-still as the coronavirus pandemic brought about lockdowns,...

Wednesday, June 3, 2020, 04:45:47 PM